Our findings have led us to propose a paradigm wherein stressor exposure during periods of mild colitis leads to an inhibition of colonic cytokines and inflammatory factors (such as IL-1β and iNOS) that have protective responses to intestinal bacteria. The gene discussed is IL1B; the disease is colitis.